Oncology Models | Charles River Discovery Services

Primary Human Tumor Grafts 

Charles River Discovery Services is aggressively building a primary human tumor graft portfolio and we expect to have validated models available in 2011. This platform is designed to deliver:

  • Early passage cryopreservation
  • Broad panels of 10 solid tumors
  • Sensitivity and resistance profiles
  • Expression and mutation profiles


Tumor samples will be available for custom analysis.

For more information about our primary human tumor grafts, contact us at askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

+33 (0)4 74 01 69 69
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.